Otivio Develops FlowOx For MS And Vascular Deficient Patients

The Norwegian company is applying a simple physiological response to costly and tricky-to-manage conditions, its leaders told Medtech Insight.

Otivio's FlowOx System • Source: Otivio

In an age of minimalist design and increasingly complex function, startup devices can often appear, from the outside, confusing, but Oslo-based Otivio AS has bucked this trend with its FlowOx device for the treatment of vascular flow deficiencies. 

FlowOx comprises of a sleeved compartment for a patient’s lower leg and a pumping system connected via tubing. When powered, FlowOx evacuates approximately five percent of the air inside, creating a pressure of roughly -40mmHg

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Wound Management

More from Device Area

Digital Health And AI Tools Advance Cardiac Event Prediction, SCAI 2025 Data Show

 
• By 

Out-of-hospital cardiac arrest remains one of the most challenging and resource-intensive emergencies in cardiovascular care. At SCAI 2025, clinicians presented a novel algorithm that improved triage decisions and reduced unnecessary interventions.

SpotitEarly Raised $20.3M In New Funding To Bring AI- And Dog-Sniffing-Powered Early Cancer Detection Test To US

 
• By 

Israeli-based SpotitEarly hopes to bring an early cancer-detection test, which uses dogs’ noses to detect compounds in exhaled breath and AI analysis, to US homes in 2026.

Thousands Of Cardiac Digital Twins Reveal Novel Connections With Mental Health

 

King’s College London, Imperial College London and The Alan Turing Institute constructed cardiac digital twins at scale, creating over 3,400, in a new study using UK Biobank data published in Nature Cardiovascular Research on 16 May.